Invacare Corporation
IVC · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $165,481 | $181,320 | $170,408 | $189,017 |
| % Growth | -8.7% | 6.4% | -9.8% | – |
| Cost of Goods Sold | $121,637 | $133,017 | $139,029 | $141,035 |
| Gross Profit | $43,844 | $48,303 | $31,379 | $47,982 |
| % Margin | 26.5% | 26.6% | 18.4% | 25.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $53,809 | $52,228 | $55,365 | $58,623 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $53,809 | $52,228 | $55,365 | $58,623 |
| Operating Income | -$31,136 | -$11,983 | -$26,080 | -$14,793 |
| % Margin | -18.8% | -6.6% | -15.3% | -7.8% |
| Other Income/Exp. Net | -$9,101 | -$5,058 | -$9,448 | -$10,382 |
| Pre-Tax Income | -$40,237 | -$20,667 | -$33,434 | -$21,023 |
| Tax Expense | $940 | -$90 | $920 | $920 |
| Net Income | -$41,177 | -$20,577 | -$34,354 | -$21,943 |
| % Margin | -24.9% | -11.3% | -20.2% | -11.6% |
| EPS | -1.08 | -0.56 | -0.91 | -0.61 |
| % Growth | -92.9% | 38.5% | -49.2% | – |
| EPS Diluted | -1.08 | -0.56 | -0.91 | -0.61 |
| Weighted Avg Shares Out | 38,037 | 36,517 | 37,680 | 35,995 |
| Weighted Avg Shares Out Dil | 38,037 | 36,517 | 37,680 | 35,995 |
| Supplemental Information | – | – | – | – |
| Interest Income | -$17 | -$11 | $10 | $1 |
| Interest Expense | $9,101 | $8,684 | $7,354 | $6,230 |
| Depreciation & Amortization | $21,171 | -$15,545 | $5,125 | $5,103 |
| EBITDA | -$9,965 | -$27,528 | -$23,986 | -$10,641 |
| % Margin | -6% | -15.2% | -14.1% | -5.6% |